Crinetics Pharmaceuticals, Inc. (CRNX) — Stock Score Summary

Crinetics Pharmaceuticals, Inc. (CRNX) has a MoatMap StockRank of 12/100 based on Quality (32/100), Value (35/100), and Momentum (29/100) factor scores. The current signal is STRONG SELL. Crinetics is a clinical-stage biopharmaceutical company that lacks the established commercial moats and owner earnings required by our investment philosophy.

Crinetics Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative oral therapeutics for rare endocrine diseases and endocrine-related tumors. The company focuses on creating convenient oral alternatives to traditional injectable treatments, with its lead candidate, paltopirdif, in advanced clinical trials for acromegaly, aiming to improve patient quality of life.

Key Financial Metrics

Price$33.15
Market Cap$3.8B
P/E (Forward)-8.23
Price/Book2.85
Return on Equity-39.2%
Return on Invested Capital-49.6%
Debt/Equity3.74
Gross Margin0.0%
Operating Margin-1307.8%
Revenue Growth2873.4%
Free Cash Flow$-242M

Crinetics Pharmaceuticals, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Crinetics Pharmaceuticals, Inc.’s (CRNX) StockRank?
MoatMap’s StockRank for Crinetics Pharmaceuticals, Inc. (CRNX) is 12/100, with a Strong Sell signal. It is a composite of Quality (32), Value (35), and Momentum (29) factor ranks across MoatMap’s 19,000+ stock universe.
Does Crinetics Pharmaceuticals, Inc. have an economic moat?
Crinetics Pharmaceuticals, Inc. (CRNX) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Crinetics Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Crinetics Pharmaceuticals, Inc. (CRNX) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Crinetics Pharmaceuticals, Inc. in?
Crinetics Pharmaceuticals, Inc. (CRNX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksCRNX deep dive reportAI ChampionsHow we score stocksSense-check another stock